8-K: ATI Physical Therapy Reports Q1 2024 Results, Driven by Clinic Operations and People Strategies

ATI Physical Therapy announced its first quarter 2024 financial results, highlighting growth in revenue and patient visits, alongside improved therapist retention.

Summary

• ATI Physical Therapy reported a net revenue of $181.5 million for the first quarter of 2024, an 8.7% increase compared to $166.9 million in the same period last year.
• Net patient revenue rose by 9.7% to $165.4 million, up from $150.8 million in Q1 2023.
• The company saw an increase in visits per day (VPD) to 23,837, a 5.0% rise from 22,701 in the first quarter of 2023.
• Rate per visit (RPV) also increased by 4.5% to $108.42, compared to $103.76 in the prior year.
• Adjusted EBITDA for the quarter was $6.5 million, a 34.9% increase from $4.8 million in Q1 2023.
• The company's net loss improved to $13.5 million, compared to a net loss of $25.2 million in the first quarter of 2023.
• ATI closed 11 clinics and divested 1 clinic during the quarter, ending with 884 clinics.
• For Q2 2024, ATI is guiding revenue between $185 million and $195 million and Adjusted EBITDA between $15 million and $20 million.

Sentiment

Score: 7

Explanation: The sentiment is positive due to the improved financial results, increased patient visits, and reduced therapist turnover. However, the company's liquidity concerns and ongoing risks temper the overall optimism.

Positives

• The company experienced significant growth in both net revenue and net patient revenue.
• Patient visits increased, indicating strong demand for ATI's services.
• The rate per visit increased, suggesting improved pricing and revenue management.
• Adjusted EBITDA saw a substantial increase, reflecting improved profitability.
• The net loss decreased significantly year-over-year, showing progress towards financial stability.
• The clinician turnover rate is exceptionally low at 16%, indicating successful people strategies.
• The company is projecting continued growth in the second quarter of 2024.

Negatives

• Salaries and related costs increased by 9.5%, primarily due to wage inflation and added staff.
• PT salaries and related costs per visit increased by 7.0%, mainly due to higher compensation per FTE.
• Rent, clinic supplies, contract labor and other costs increased by 4.5%, driven by higher spending on contract labor.
• Provision for doubtful accounts increased to $5.0 million from $4.1 million in the first quarter of 2023.
• Operating cash use was $39.1 million compared to $14.2 million in the first quarter of 2023, reflecting certain timing differences between accrual and cash basis.
• No new clinics were opened in the quarter, and 12 clinics were closed or divested.

Risks

• The company's liquidity position raises substantial doubt about its ability to continue as a going concern.
• There are risks associated with meeting financial covenants required by the 2022 Credit Agreement.
• The company faces risks related to outstanding indebtedness and preferred stock, rising interest rates, and potential increases in borrowing costs.
• There are risks related to the company's ability to access additional financing or alternative options when needed.
• The company is dependent on governmental and third-party private payors for reimbursement, and decreases in reimbursement rates could adversely affect financial results.
• The company faces competition in a rapidly changing industry, including competition for skilled physical therapists.
• There are risks associated with the locations of clinics and the potential need to close clinics and incur closure costs.
• The company is subject to extensive regulation and macroeconomic uncertainty.
• There are risks associated with the company's ability to attract and retain talented executives and employees.
• The company faces risks related to dilution of common stock ownership interests.

Future Outlook

ATI expects net revenue to be between $185 million and $195 million and Adjusted EBITDA to be between $15 million and $20 million for the second quarter of 2024, anticipating continued growth in patient visits.

Management Comments

• Sharon Vitti, Chief Executive Officer, stated that the company grew again in the first quarter, seeing approximately 1,100 more patient visits each day compared to this time last year.
• Ms. Vitti also noted that the company's performance continues to affirm that they have the right people and strategies in place.
• Joe Jordan, Chief Financial Officer, said that they continued to deliver progress in financial results through their people and operations strategies.
• Mr. Jordan also stated that they are pleased with the progress made and are expecting continued year-over-year growth as they progress through 2024.

Industry Context

This announcement reflects a trend in the healthcare industry where outpatient services are seeing increased demand. The focus on operational efficiency and talent management is also a common theme among healthcare providers seeking to improve profitability and patient care.

Comparison to Industry Standards

• ATI's 8.7% revenue growth is solid compared to some of its peers in the outpatient physical therapy sector, although specific competitor data is not provided in this document.
• The 16% clinician turnover rate is notably low, suggesting a strong competitive advantage in talent retention compared to industry averages, which can be significantly higher.
• The Adjusted EBITDA margin of 3.6% is an improvement year-over-year, but still indicates room for further improvement compared to some more profitable healthcare service providers.
• The company's focus on clinic optimization and footprint management is a common strategy in the industry to improve efficiency and profitability, similar to what companies like Select Medical and U.S. Physical Therapy have implemented.

Stakeholder Impact

• Shareholders will likely view the improved financial results and reduced net loss positively.
• Employees, particularly clinicians, will benefit from the company's focus on talent retention and culture.
• Patients will benefit from increased access to care and improved service quality.
• Creditors will be concerned about the company's liquidity position and ability to meet financial obligations.

Next Steps

• Management will host a conference call on May 6, 2024, to review the first quarter 2024 financial results.
• The company will continue to execute on its commercial, people, and operations strategies to grow patient visits through 2024.

Key Dates

Keywords

physical therapy, outpatient, healthcare, revenue, EBITDA, patient visits, clinic operations, therapist retention, financial results, growth